Meditation and Exercise to Treat Chronic Back Pain (MedExT)

April 1, 2021 updated by: Matthew Kostek, Duquesne University

Combined Meditation and Exercise as a Treatment for Patients With Chronic Back Pain

This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The investigators hypothesize that a combination treatment reduces disability and pain more than the control intervention.

Study Overview

Status

Completed

Detailed Description

Exercise and mindfulness based mediation can both produce analgesic effects in patients with chronic pain, but the mechanisms are not clear.

Combining treatments could produce analgesic effects that are additive, synergistic, or counteractive to each other. Here, the investigators examine the effects of a 4-week intervention in patients with chronic low back pain. Patients are assigned to a meditation/exercise group or a control group. The investigators will measure pain and disability using a variety of tools including surveys (disability, anxiety, mindfulness, and pain), pain VAS scales, and quantitative sensory testing.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15282
        • Duquesne University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Presence of clinically diagnosed nonspecific low back pain for at least 6 months
  2. Body mass index within the normal to overweight range (18.5-29.9)
  3. Resting heart rate 60 to 100 beats per minute
  4. Resting blood pressure less than or equal to 140/90
  5. Able to independently ambulate community distances without external support (e.g., walker, cane)

    Exclusion Criteria:

  6. Age less than 18 or greater than 60 years
  7. BMI ≥ 30 or ≤ 18.4
  8. Cardiovascular or respiratory disease
  9. Neurological disease, unrelated to low back pain
  10. Radicular low back pain
  11. Back pain associated with neuropathy
  12. Diabetes mellitus, Types 1 and 2
  13. Diagnosed with a chronic pain condition, unrelated to low back pain
  14. Acute pain
  15. Regular participation in high intensity athletic/sporting activities
  16. Sedentary lifestyle
  17. Currently pregnant
  18. Current cigarette smoker
  19. On-going litigation associated with back pain
  20. Inability to walk independently without external support (e.g. walker).
  21. Regular participation in meditation techniques or training in Mindfulness-based stress reduction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise and Meditation
The Exercise and Meditation group will practice mindfulness meditation immediately before walking treadmill exercise, five days per week for four weeks.
The Exercise and Meditation group will listen to recorded meditations (15 minutes) that are based on mindfulness. They will then walk on a treadmill for 30 minutes at a moderate intensity. The intervention is completed five days per week for four weeks.
Sham Comparator: Control
The Control group will listen to an audio book followed by quiet rest, five days per week for four weeks.
The Control group will listen to a recorded audio book for 15 minutes, They will then sit quietly for 30 minutes. The intervention is completed five days per week for four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Roland Morris Disability Questionnaire
Time Frame: baseline and 4 weeks
The Roland-Morris Disability Questionnaire is designed to assess self-rated physical disability caused by low back pain. The patient is asked to tick a statement when it applies to him that specific day, this makes it possible to follow changes in time. The end score is the sum of the ticked boxes. The score ranges from 0 (no disability) to 24 (max. disability).
baseline and 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Cutaneous Sensation
Time Frame: baseline and 4 weeks
Subjects will be examined using cutaneous sensory filaments on the forearm with data recorded in grams.
baseline and 4 weeks
Fear Avoidance Beliefs Questionnaire
Time Frame: baseline and 4 weeks
The Fear-Avoidance Beliefs Questionnaire (FABQ) is a questionnaire based on the Fear-Avoidance Model of Exaggerated Pain Perception, a model created in attempts to explain why some patients with acute painful conditions can recover while other patients develop chronic pain from such conditions. The FABQ measures patients' fear of pain and consequent avoidance of physical activity because of their fear. This questionnaire consists of 16 items, with each item scored from 0-6. Higher scores on the FABQ are indicative of greater fear and avoidance beliefs
baseline and 4 weeks
Freiburg Mindfulness Inventory
Time Frame: baseline and 4 weeks
The FMI is a 14-item questionnaire for measuring mindfulness. It is most suitable in generalized contexts, where knowledge of the Buddhist background of mindfulness cannot be expected. The 14 items cover all aspects of mindfulness. The purpose is to characterize the experience of mindfulness. The subject is asked to answer every statement as honestly and spontaneously as possible. Each statement is scored on a 1 to 4 scale and a composite score is calculated from all statements.
baseline and 4 weeks
VAS back pain (intensity & unpleasantness)
Time Frame: baseline, daily (pre and post intervention), and 4 weeks
Participants will be asked to rate their current level of back pain intensity on a Visual Analog Scale (VAS) ranging from 0 to 10
baseline, daily (pre and post intervention), and 4 weeks
State-Trait Anxiety Inventory (STAI)
Time Frame: baseline and 4 weeks
The STAI is an introspective psychological inventory consisting of 40 self-report items pertaining to anxiety affect. It distinguishes between a person's state and trait anxiety levels. The A-Trait and A-State scales comprise 20 items each, scored on a 4-point Likert-type response scale. Higher STAI scores suggest higher levels of anxiety.
baseline and 4 weeks
Change in Pressure Sensation
Time Frame: baseline and 4 weeks
Subjects will be examined using a pressure algometer to determine a pressure pain threshold, measured in Newtons
baseline and 4 weeks
Change in Heat unpleasantness
Time Frame: baseline and 4 weeks
Subjects will be examined using a heat block with a determined temperature threshold. Subjects will report unpleasantness using a VAS scale.
baseline and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Matthew C. Kostek, PhD, Duquesne University
  • Principal Investigator: Benedict J Kolber, PhD, Duquesne University
  • Principal Investigator: Eric Helm, MD, University of Pittsburgh

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2018

Primary Completion (Actual)

March 31, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

October 17, 2017

First Submitted That Met QC Criteria

October 24, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

April 5, 2021

Last Update Submitted That Met QC Criteria

April 1, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Protocol50

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Exercise and Meditation

3
Subscribe